Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents

Journal of Liposome Research

Volumn 17, Issue 1, 2007, Pages 1-14

  Elbayoumi, Tamer A ^a   Pabba, Santosh ^a   Roby, Aruna ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Antinuclear antibody; Doxorubicin; Gamma imaging; Lipid core micelles; Liposomes; Photodynamic therapy; Tumor targeting

Indexed keywords

DOXORUBICIN; LIPID; LIPOSOME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2C5; NUCLEOSOME ANTIBODY; PENTETATE INDIUM IN 111; PORPHYRIN DERIVATIVE; TETRAPHENYLPORPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICELLE; MOUSE; NONHUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; TUMOR; TUMOR CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; FEMALE; HUMANS; LIPOSOMES; MALE; MICE; MICE, NUDE; MICELLES; NUCLEOSOMES; PENTETIC ACID; RADIOIMMUNODETECTION;

EID: 34247366411     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100601186474     Document Type: Article

References (21)

1. Boldicke, T., Emery, S. C., Reubke, B. (1991). In vitro immunization of mouse spleen cells using protein and peptide antigens, Chapman and Hall medical.
2. 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts. Cancer Res. 53(12):2834-2839.
3. Chakilam, A. R., Pabba, S., Mongayt, D., Iakobouv, L. Z., Torchilin, V. P. (2004). A single monoclonal antinuclear autoantibody with nucleosome-restricted specificity inhibits the growth of diverse human tumors in nude mice. Cancer Ther. 2(4):353-364.
4. Colnaghi, M. I., Menard, S., et al. (1977). Natural anti-tumor serum reactivity in BALB/c mice. II. Control by regulator T-cells. Int. J. Cancer 19(2):275-280.
5. Davis, S., Abuchowski, A., et al. (1981). Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol. Clin. Exp. Immunol. 46(3):649-452.
6. De Santes, K., Slamon, D., et al. (1992). Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res. 52(7):1916-1923.
7. Iakoubov, L. Z., Rokhlin, O., et al. (1995). Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunol Lett. 47(1-2):147-149.
8. Iakoubov, L. Z. and Torchilin, V. P. (1997). A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice. Oncol Res. 9(8):439-446.
9. Iakoubov, L. Z. and Torchilin, V. P. (1998). Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detect. Prev. 22(5):470-475.
10. Lasch, L., Weissig, V., Brandl, M. (2003). Preparation of liposomes. Liposomes: a practical approach. V. P. Torchilin and V. Weissig. Oxford ; New York, Oxford University Press: 3-29.
11. Lukyanov, A. N., Elbayoumi, T. A., et al. (2004). Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Control Release 100(1):135-144.
12. Lukyanov, A. N., Gao, Z., et al. (2003). Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J. Control Release 91(1-2): 97-102.
13. Palmer, T. N., Caride, V. J., et al. (1984). The mechanism of liposome accumulation in infarction. Biochim. Biophys. Acta 797(3):363-368.
14. Reichert, J. M. (2002). Therapeutic monoclonal antibodies: trends in development and approval in the US. Curr. Opin. Mol. Ther. 4(2):110-118.
15. Roby, A., Erdogan, S., et al. (2006). Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur. J. Pharm. Biopharm. 62(3):235-240.
16. Samokhin, G. P., Mongayt, D. A., et al. (2001). Negatively charged polymers protect antinuclear antibody against inactivation by acylating agents. Anal. Biochem. 292(2):245-249.
17. Torchilin, V. P., Iakoubov, L. Z., et al. (2001a). Antinuclear autoantibodies as potential antineoplastic agents. Trends Immunol. 22(8):424-427.
18. Torchilin, V. P., Levchenko, T. S., et al. (2001b). p- Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim. Biophys. Acta 1511(2):397-411.
19. Torchilin, V. P., Rammohan, R., et al. (2001c). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA 98(15):8786-8791.
20. Torchilin, V. P., Lukyanov, A. N., et al. (2003). Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. USA. 100(10):6039-6044.
21. Xu, F. J., Yu, Y. H., et al. (1997). Radioiodinated antibody targeting of the HER-2/neu oncoprotein. Nucl. Med. Biol. 24(5):451-459.